Dr. Stephen Anthony Morse, DO

Dr. Morse practices at Gentilly Dialysis in New Orleans, Louisiana.

Dr. Morse's NPI, 1396767034, was assigned on July 24, 2006. Dr. Morse holds Louisiana license 06198R.

Dr. Morse's primary practice is Gentilly Dialysis, at 1542 Tulane Ave, New Orleans, LA 70112 in Orleans Parish. The practice phone is (504) 283-9098.

Dr. Morse's primary practice is Gentilly Dialysis in New Orleans, Louisiana. Dr. Morse is also affiliated with University Medical Center New Orleans. The medical group on file is LSU Healthcare Network. Dmand AI also links Dr. Morse to 3 more hospitals, 2 group practices and clinics, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morse practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Morse's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Morse is licensed in Louisiana.

CMS data shows 142 Medicare services from Dr. Morse across 3 procedure codes in 2024, for 60 Medicare patients. Medicare paid $9,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Morse in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 62% are also on Medicaid. Their average risk score is 5.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morse's median patient age at 70, with 55% women.

In 2024, Dr. Morse wrote 249 Medicare Part D claims for 68 patients. 82% of them were for generic drugs. CMS names the drug for 123 of them, across 8 drugs with 11 or more claims each, at $3,803 in total drug cost. In 2023, CMS named 385 claims across 15 drugs.

Dr. Morse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 250 general payments to Dr. Morse from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $1,399. It also lists 11 research payments totaling $1,274 in 2019.